BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5617980)

  • 1. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
    Arrigo A
    Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver damage due to chlorpromazine and its treatment with arginine glucose-1-phosphate].
    Poggi E; Ferrari G
    Epatologia; 1971; 17(1):127-31. PubMed ID: 5147857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arginine glucose-1-phosphate in liver lesions due to antiepileptic drugs. Its effectiveness on the frequency of epileptic crises. Pathogenesis of the epileptic attack].
    Telatin L
    Epatologia; 1970; 16(3):281-6. PubMed ID: 5525738
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glucose-1-phosphate of arginine in the therapy of some mental complications of chronic alcoholism (pre- and delirium tremens)].
    Morino G
    Minerva Med; 1967 Mar; 58(19):793-6. PubMed ID: 6021857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of blood ammonia in liver patients treated with arginine-glucose-1-phosphate].
    Novelli E; Pinacci U
    Z Gesamte Inn Med; 1967 Nov; 22(22):704-9. PubMed ID: 5623736
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative clinical research on the effect of arginine glucose-1 phosphate in liver cirrhosis and precirrhotic forms].
    Pedrazzi F; Serantini M; Zanini S
    Minerva Gastroenterol; 1969; 15(1):20-48. PubMed ID: 5385839
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of alcoholic liver disease: studies of 10 cases].
    Silvi G; Stellato S
    Clin Ter; 1978 Feb; 84(3):275-82. PubMed ID: 639480
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electroencephalographic study of neuro-encephalopathies due to chronic involutional hepatitis treated with arginine glucose-1-phosphate].
    Parravicini M; Salmini G
    Epatologia; 1970; 16(1):49-55. PubMed ID: 5525566
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate].
    Arias Vallejo E
    Folia Clin Int (Barc); 1966 Sep; 16(9):404-15. PubMed ID: 5990974
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z; Korolko A
    Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of the intravenous administration of a combination of amino acids and of an antitoxic liver extract].
    Malvicini G; Tinozzi S
    Minerva Med; 1968 Mar; 59(19):1027-33. PubMed ID: 5646216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
    AlvisÄ­ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
    Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trial of LL 650 in various hepatic diseases].
    Savoye B; Dietsch R; Chapuy M; Girard M
    J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the action of a total liver extract in subacute and chronic hepatopathies].
    Bazzicalupo G; Coscelli C
    Minerva Med; 1968 Sep; 59(76):3977-82. PubMed ID: 5698739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.